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Objective
To evaluate the effectiveness, safety, and tolerability of a
12-month treatment with low doses of methadone (MT)
(mean MT dosage 12.3 mg ± SD 7.3) as prophylaxis in





Since May 3rd, 2012 up to January 8th, 2015, we enrolled
24 patients (18 females, 6 males; average age, 48 years)
who were considered eligible to be treated with metha-
done. Nine patients dropped out because of adverse drug
reactions (n=4, mean time of drop-out 7 days) or treat-
ment ineffectiveness (n=5, mean time of drop-out
6 months). Six patients completed the 12-month treat-
ment. After 1-year follow-up they still reported daily head-
ache, however, they showed an impressive decrease of
analgesic and/or antimigraine drug consumption (from
147.7 medications per month ± SD 124 to 8.5 medications
per month ± SD 6.1) and a significant decrease of visual
analogic scale (VAS) pain intensity (from 5.8 ± SD 2.6 to
2.8 ± SD 2.1). These patients were treated with daily
methadone doses ranging from 5 mg to 60 mg; methadone
dosages were safe and well tolerated.
Conclusions
In patients affected by daily refractory headache and medi-
cation-overuse headache, who are exposed to the risk of
serious side effects due to prolonged analgesic and/or anti-
migraine treatment, prophylaxis with low-dose methadone
therapy seems to represent an effective therapeutic option.
Written informed consent to publication was obtained
from the patient(s).
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